The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Stem cells from bone marrow, skeletal muscle and possibly other tissues can be identified by the 'side-population' (SP) phenotype. Although it has been assumed that expression of ABC transporters is responsible for this phenotype, the specific molecules involved have not been defined. Here we show that expression of the Bcrp1 (also known as Abcg2 murine/ABCG2 human) gene is a conserved feature of stem cells from a wide variety of sources. Bcrp1 mRNA was expressed at high levels in primitive murine hematopoietic stem cells, and was sharply downregulated with differentiation. Enforced expression of the ABCG2 cDNA directly conferred the SP phenotype to bone-marrow cells and caused a reduction in maturing progeny both in vitro and in transplantation-based assays. These results show that expression of the Bcrp1/ABCG2 gene is an important determinant of the SP phenotype, and that it might serve as a marker for stem cells from various sources.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Side population cells express ATP-binding cassette transporter (ABCG2/Brcp1) on the cell surface and have the ability to efflux the DNA binding dye Hoechst 33 342 (Zhou et al., 2001).”
From Endometriosis and nuclear receptors (2019) · cites this paper as Zhou et al., 2001
Citations
Cites
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1797 · Cited by 2,903
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
Lagasse, E., Connors, H., Al-Dhalimy, M., Reitsma, M., Dohse, M., Osborne, L., Wang, X., Finegold, M., Weissman, I. L., & Grompe, M. (2000) · Nature Medicine · doi:10.1038/81326 · Cited by 2,314
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Self-citationDystrophin expression in the mdx mouse restored by stem cell transplantation
Gussoni, E., Soneoka, Y., Strickland, C. D., Buzney, E. A., Khan, M. K., Flint, A. F., Kunkel, L. M., & Mulligan, R. C. (1999) · Nature · doi:10.1038/43919 · Cited by 1,802
Goodell, M. A., Rosenzweig, M., Kim, H., Marks, D. F., DeMaria, M., Paradis, G., Grupp, S. A., Sieff, C. A., Mulligan, R. C., & Johnson, R. P. (1997) · Nature Medicine · doi:10.1038/nm1297-1337 · Cited by 1,089
A safe packaging line for gene transfer: separating viral genes on two different plasmids
Markowitz, D., Goff, S., & Bank, A. (1988) · Journal of Virology · doi:10.1128/jvi.62.4.1120-1124.1988 · Cited by 1,061
Hematopoietic potential of stem cells isolated from murine skeletal muscle
Jackson, K. A., Mi, T., & Goodell, M. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14482 · Cited by 955
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
Chaudhary, P. M., & Roninson, I. B. (1991) · Cell · doi:10.1016/0092-8674(91)90141-k · Cited by 934
Cited by
Items 601–700 of 1,005
Identification of cancer stem cell markers in human malignant mesothelioma cells
Ghani, F. I., Yamazaki, H., Iwata, S., Okamoto, T., Aoe, K., Okabe, K., Mimura, Y., Fujimoto, N., Kishimoto, T., Yamada, T., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.054 · Cited by 80
Yin, L., Castagnino, P. A., & Assoian, R. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2545 · Cited by 84
Wu, A., Luo, W., Zhang, Q., Yang, Z., Zhang, G., Li, S., & Yao, K. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.046 · Cited by 83
Yu, M., Xiao, Z., Shen, L., & Li, L. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04826.x · Cited by 82
Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?
Plasschaert, S. L. A., Kamps, W. A., Vellenga, E., de Vries, E. G. E., & de Bont, E. S. J. M. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00140-3 · Cited by 80
miRNA-720 Controls Stem Cell Phenotype, Proliferation and Differentiation of Human Dental Pulp Cells
Hara, E. S., Ono, M., Eguchi, T., Kubota, S., Pham, H. T., Sonoyama, W., Tajima, S., Takigawa, M., Calderwood, S. K., & Kuboki, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083545 · Cited by 88
“In order to overcome such hindrance, we have based our strategy on the properties of stem cells to efflux Hoechst-33342 dye through ATP binding cassette (ABC) transporters [16,17].”
MethodABCG2 (BCRP) expression in normal and malignant hematopoietic cells
Abbott, B. L. (2003) · Hematological Oncology · doi:10.1002/hon.714 · Cited by 87
Epidermal stem cells are resistant to cellular aging
Stern, M. M., & Bickenbach, J. R. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00318.x · Cited by 79
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells
Dando, I., Cordani, M., Pozza, E. D., Biondani, G., Donadelli, M., & Palmieri, M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/425708 · Cited by 82
Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
Muñoz-Galván, S., & Carnero, A. (2020) · Cells · doi:10.3390/cells9061402 · Cited by 85
“These cells overexpress membrane ABC transporters that facilitate the efflux chemotherapeutic agents, leading to therapy resistance [15,40].”
BackgroundMorphine promotes cancer stem cell properties, contributing to chemoresistance in breast cancer
Niu, D.-G., Peng, F., Zhang, W., Guan, Z., Zhao, H.-D., Li, J.-L., Wang, K.-L., Li, T., Zhang, Y., Zheng, F.-M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2894 · Cited by 83
“the elevation of the ABC transporters that function to efflux chemotherapeutic drugs [5]; 2.”
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
Liu, Y., Chang, T., Tsai, M., Wu, S., Tsai, T.-H., Chen, H., Yu, S., Yang, J. C., & Shih, J. (2015) · Oncotarget · doi:10.18632/oncotarget.3389 · Cited by 79
“Side population cells are abundant of ATP-binding cassette (ABC) transporters [48].”
BackgroundGuha, P., Bandyopadhyaya, G., Polumuri, S. K., Chumsri, S., Gade, P., Kalvakolanu, D. V., & Ahmed, H. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2912-z · Cited by 80
Gao, W., Wu, D., Wang, Y., Wang, Z., Zou, C., Dai, Y., Ng, C., Teoh, J. Y., & Chan, F. L. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0987-x · Cited by 82
“Based on the conserved feature of high drug efflux capacity and expression of efflux membrane transporters, particularly ABCG2 in SCs or SPs derived from various tissue origins [22], sorting of SP cells by exclusion of DNA dye Hoechst 33342 is another flow cytometry–based method used for isolation of CSCs with high tu…”
MethodPearce, D. J., & Bonnet, D. A. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.06.002 · Cited by 78
Bladder cancer stem cells: clonal origin and therapeutic perspectives
Li, Y., Lin, K., Yang, Z., Han, N., Quan, X., Guo, X., & Li, C. (2017) · Oncotarget · doi:10.18632/oncotarget.19112 · Cited by 85
“This was previously used as the principle for isolating the side population (SP) CSCs [69].”
MethodKarachaliou, N., Rosell, R., & Viteri, S. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2013.01.01 · Cited by 78
“Some cancer stem cells (CSCs) have, on their cell surface, ATP-binding cassette transporters (ABCG) that pump out the DNA-binding dye Hoechst 33342 and are characterized as side population (SP) cells (4).”
BackgroundJiang, P., Chen, A., Wu, X., Zhou, M., Haq, I. U., Mariyam, Z., & Feng, Q. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26288 · Cited by 77
“Furthermore, side population (SP) cells are a subgroup of cells, which can exhibit canonical stem cell characteristics and pump out Hoechst 33342 (Zhou et al., 2001).”
BackgroundTranscriptional Profiling of Enriched Populations of Stem Cells Versus Transient Amplifying Cells
Zhou, M., Li, X., & Lavker, R. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600777200 · Cited by 83
Retinal properties and potential of the adult mammalian ciliary epithelium stem cells
Das, A. V., James, J., Rahnenführer, J., Thoreson, W. B., Bhattacharya, S., Zhao, X., & Ahmad, I. (2005) · Vision Research · doi:10.1016/j.visres.2004.12.017 · Cited by 77
Cell based therapy for duchenne muscular dystrophy
Farini, A., Razini, P., Erratico, S., Torrente, Y., & Meregalli, M. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21895 · Cited by 90
Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors
Gaur, P., Sceusi, E. L., Samuel, S., Xia, L., Fan, F., Zhou, Y., Lu, J., Tozzi, F., Lopez‐Berestein, G., Vivas‐Mejía, P. E., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.037 · Cited by 82
Isolation and characterization of tumor stem-like cells from human meningiomas
Hueng, D., Sytwu, H., Huang, S., Chang, C., & Ma, H. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0469-1 · Cited by 77
“Characteristic features of tumor stem-like cells include spherical formations, self-renewal, presence of stem-like markers, expression of stemness genes such as ABCG2 [11–13] and CD133 [14–20], chemotherapeutic and radiotherapeutic resistance [16–22], and potent tumorigenicity in vivo.”
BackgroundZhou, T., Zhang, S.-L., He, C., Zhuang, Q.-Y., Han, P., Jiang, S., Yao, H., Huang, Y., Ling, W., Lin, Y., et al. (2017) · Theranostics · doi:10.7150/thno.17647 · Cited by 77
van der Heijden, J., de Jong, M. C., Dijkmans, B. A. C., Lems, W. F., Oerlemans, R., Kathmann, I., Schalkwijk, C. G., Scheffer, G. L., Scheper, R. J., & Jansen, G. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2002.005249 · Cited by 85
Culture of Specific Cell Types
Freshney, R. I. (2005) · Wiley eBooks · doi:10.1002/0471747599.cac023 · Cited by 78
Tiwari, R., Manzar, N., Bhatia, V., Yadav, A., Nengroo, M. A., Datta, D. B., Carskadon, S. L., Gupta, N., Sigouros, M., Khani, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14184-0 · Cited by 81
Hedgehog Pathway Inhibitor HhAntag691 Is a Potent Inhibitor of ABCG2/BCRP and ABCB1/Pgp
Zhang, Y., Laterra, J., & Pomper, M. G. (2009) · Neoplasia · doi:10.1593/neo.81264 · Cited by 76
Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells
Schrickx, J. A., Lektarau, Y., & Fink‐Gremmels, J. (2005) · Archives of Toxicology · doi:10.1007/s00204-005-0041-5 · Cited by 76
Hegedüs, C., Truta-Feles, K., Antalffy, G., Várady, G., Német, K., Özvegy‐Laczka, C., Kéri, G., Őrfi, L., Szakács, G., Settleman, J. E., et al. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.010 · Cited by 81
“It has been shown previously that conformational changes of ABCG2 can be monitored with the anti-ABCG2 5D3 antibody [4,30].”
BackgroundMethodNon-side-population hematopoietic stem cells in mouse bone marrow
Morita, Y., Ema, H., Yamazaki, S., & Nakauchi, H. (2006) · Blood · doi:10.1182/blood-2006-03-010207 · Cited by 77
Self-citationSharma, S., Mohanty, S., Gupta, D., Jassal, M., Agrawal, A. K., & Tandon, R. (2011) · PubMed Central · Cited by 76
Sezer, A. D. (2016) · InTech eBooks · doi:10.5772/60475 · Cited by 81
Dysfunctional Resident Lung Mesenchymal Stem Cells Contribute to Pulmonary Microvascular Remodeling
Chow, K. S., Fessel, J. P., Ihida‐Stansbury, K., Schmidt, E. P., Gaskill, C. F., Alvarez, D. F., Graham, B. B., Harrison, D. G., Wagner, D. H., Nozik‐Grayck, E., et al. (2013) · Pulmonary Circulation · doi:10.4103/2045-8932.109912 · Cited by 77
“We engineered an EC-SOD conditional knockout by crossing the ABCG2 mice with loxpsod3 mice.[22,43,50,51] This novel inducible system, along with titration of tamoxifen dosing, allowed the assay of lung MSC phenotype and function In vivo by knocking out EC-SOD in the cells of interest.”
BackgroundMethodTsunoda, S., Okumura, T., Ito, T., Kondo, K., Ortiz‐Villalón, C., Tanaka, E. I., Watanabe, G., Itami, A., Sakai, Y., & Shimada, Y. (2006) · Oncology · doi:10.1159/000106787 · Cited by 75
Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics
Jani, M., Temesszentandrási‐Ambrus, C., Magnan, R., Jakab, K. T., Beéry, E., Zolnerciks, J. K., & Krajcsi, P. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1224-8 · Cited by 86
“Bcrp was subsequently demonstrated to be the hallmark of the SP phenotype in a set of experiments involving hematopoietic stem cells from Mdr1a/b and Bcrp knockout mice, and ABCG2-transfected Saos-2 cells that expelled the Hoechst dye but not rhodamine 123 (Zhou et al. 2001).”
BackgroundMethodThe Genetic Polymorphism of Drug Transporters: Functional Analysis Approaches
Ishikawa, T., Tsuji, A., Inui, K., Sai, Y., Anzai, N., Wada, M., Endou, H., & Sumino, Y. (2004) · Pharmacogenomics · doi:10.1517/phgs.5.1.67.25683 · Cited by 79
Transcription Factor Oct1 Is a Somatic and Cancer Stem Cell Determinant
Maddox, J., Shakya, A., South, S., Shelton, D. N., Andersen, J. N., Chidester, S., Kang, J., Gligorich, K. M., Jones, D. A., Spangrude, G. J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003048 · Cited by 79
“dye efflux activity, including in A549 cells [43], and stem cell chemoresistance [42].”
BackgroundHematopoietic Stem Cell Characterization and Isolation
Rossi, L., Challen, G. A., Sirin, O., Lin, K., & Goodell, M. A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-145-1_3 · Cited by 85
miR-145 Inhibits Migration and Invasion of Glioma Stem Cells by Targeting ABCG2
Shi, L., Wang, Z., Sun, G., Wan, Y., Guo, J. X., & Fu, X. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8305-y · Cited by 75
“Why did knockdown of ABCG2 expression not decrease MMP-2/9 expression, but decrease the MMP-2/9 activity? Through the literature review, we found that TIMPs could bind the active site of MMPs by N-terminal cysteine residue of the ribbon, resulting in closing the activation of active MMPs, or preventing activation of i…”
BackgroundStructure and Function of Hepatobiliary ATP Binding Cassette Transporters
Kroll, T., Prescher, M., Smits, S. H. J., & Schmitt, L. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00659 · Cited by 82
Bone Morphogenetic Proteins Regulate Tumorigenicity in Human Glioblastoma Stem Cells
Piccirillo, S. G. M., & Vescovi, A. L. (2007) · Springer eBooks · doi:10.1007/2789_2007_044 · Cited by 72
Tissue engineering with muscle-derived stem cells
Deasy, B. M., Li, Y., & Huard, J. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.08.004 · Cited by 73
Kobayashi, I., Saito, K., Moritomo, T., Araki, K., Takizawa, F., & Nakanishi, T. (2007) · Blood · doi:10.1182/blood-2007-08-104299 · Cited by 73
Katayama, R., Koike, S., Sato, S., Sugimoto, Y., Tsuruo, T., & Fujita, N. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01288.x · Cited by 81
Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigm
Garson, K., & Vanderhyden, B. C. (2014) · Reproduction · doi:10.1530/rep-14-0234 · Cited by 73
“The SP fraction or Hoechst dim cells expressed ABCG2 and the stem cell markers OCT4, NANOG and STELLAR (Hu et al. 2010). www.reproduction-online.org While the SP assay is useful for enrichment of putative stem cells, the retention of Hoechst dye within cells in this assay reflects a dynamic interplay between drug effl…”
BackgroundInfluentialDas, B., Bayat‐Mokhtari, R., Tsui, M., Lotfi, S., Tsuchida, R., Felsher, D. W., & Yeger, H. (2012) · STEM CELLS · doi:10.1002/stem.1142 · Cited by 72
Human and Mouse Hematopoietic Stem Cells Are a Depot for Dormant Mycobacterium tuberculosis
Tornack, J., Reece, S. T., Bauer, W. M., Vogelzang, A., Bandermann, S., Zedler, U., Stingl, G., Kaufmann, S. H. E., & Melchers, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169119 · Cited by 92
Yanase, K., Tsukahara, S., Mitsuhashi, J., & Sugimoto, Y. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.04.039 · Cited by 81
Huang, H., & Tang, X.-M. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000062890.40534.1c · Cited by 73
Zhang, Y., Piao, B., Zhang, Y., Hua, B., Hou, W., Xu, W.-R., Qi, X., Zhu, X., Pei, Y., & Lin, H. (2010) · Medical Oncology · doi:10.1007/s12032-010-9721-y · Cited by 73
The stem cell marker nestin predicts poor prognosis in human melanoma
Piras, F. (2009) · Oncology Reports · doi:10.3892/or_00000601 · Cited by 77
Functional expression of ABCG2 transporter in human neural stem/progenitor cells
Islam, M. O., Kanemura, Y., Tajria, J., Mori, H., Kobayashi, S., Hara, M., Yamasaki, M., Okano, H., & Miyake, J. (2005) · Neuroscience Research · doi:10.1016/j.neures.2005.01.013 · Cited by 72
Molecular basis of pregnancy-induced breast cancer protection
Russo, J., Balogh, G., Heulings, R., Mailo, D., Moral, R., Russo, P. A., Sheriff, F. S., Vanegas, J. E., & Russo, I. H. (2006) · European Journal of Cancer Prevention · doi:10.1097/00008469-200608000-00006 · Cited by 77
Kang, M. K., Hur, B. I., Ko, M. H., Kim, C. H., Cha, S. H., & Kang, S. K. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-15 · Cited by 72
Balasubramanian, P., Lamba, J. K., Strom, S. C., Sparreboom, A., Thummel, K. E., Watkins, P. B., & Schuetz, E. G. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.018366 · Cited by 78
Assessment of the effect of α-galactosides injected during embryogenesis on selected chicken traits
Pilarski, R., Bednarczyk, M. F., Lisowski, M., Rutkowski, A., Bernacki, Z., Wardeńska, M., & Gulewicz, K. (2005) · Folia Biologica · doi:10.3409/1734916054663474 · Cited by 73
Russo, J., Balogh, G., Chen, J., Fernandez, S. V., Fernbaugh, R., Heulings, R., Mailo, D., Moral, R., Russo, P. A., Sheriff, F. S., et al. (2006) · Frontiers in bioscience · doi:10.2741/1788 · Cited by 78
Núñez‐Sánchez, M. Á., Karmokar, A., González‐Sarrías, A., García-Villalba, R., Tomás-Barberán, F. A., García‐Conesa, M., Brown, K., & Espín, J. C. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.03.011 · Cited by 78
QSAR analysis and molecular modeling of ABCG2-specific inhibitors
Nicolle, E., Boumendjel, A., Macalou, S., Genoux, E., Ahmed-Belkacem, A., Carrupt, P.-A., & Di Pietro, A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.10.004 · Cited by 71
Frank, N. Y., Kho, A. T., Schatton, T., Murphy, G. F., Molloy, M. J., Zhan, Q., Ramoni, M. F., Frank, M. H., Kohane, I. S., & Gussoni, E. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200511036 · Cited by 79
The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2)
Hardwick, L., Velamakanni, S., & van Veen, H. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707218 · Cited by 79
Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
Maier, H. J., Wirth, T., & Beug, H. (2010) · Cancers · doi:10.3390/cancers2042058 · Cited by 75
Head and neck cancer stem cells: The side population
Tabor, M. H., Clay, M. R., Owen, J. H. J., Bradford, C. R., Carey, T. E., Wolf, G. T., & Prince, M. E. P. (2010) · The Laryngoscope · doi:10.1002/lary.21032 · Cited by 74
Chandler, K. J., Barrier, M., Jeffay, S. C., Nichols, H. P., Kleinstreuer, N., Singh, A. V., Reif, D. M., Sipes, N. S., Judson, R., Dix, D. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018540 · Cited by 71
“In the context of stem cells, Abcg2 is expressed in both mouse [49] and human [50] ES cells as well as numerous tissue-specific stem cell side populations [51].”
Sun, W. Y., Kajimoto, Y., Inoue, H., Miyatake, S., Ishikawa, T., & Kuroiwa, T. (2012) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2012.06.003 · Cited by 71
Wu, J., Liu, Y., Tang, Y., Wang, S., Wang, C., Li, Y., Su, X., Tian, J., Tian, Y., Pan, J., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b05677 · Cited by 72
Uchida, N., Dykstra, B. J., Lyons, K. J., Leung, F. Y. K., Kristiansen, M., & Eaves, C. J. (2004) · Blood · doi:10.1182/blood-2003-11-3989 · Cited by 71
Roy, L., & Dahl, K. D. C. (2018) · Cancers · doi:10.3390/cancers10080241 · Cited by 74
“Pathways That Promote Stemness and Chemoresistance in HGSOC We chose to focus on the major pathways that drive both stemness and chemoresistance in HGS ovarian cancer.”
BackgroundInfluentialNakagawa, H., Tamura, A., Wakabayashi, K., Hoshijima, K., Komada, M., Yoshida, T., Kometani, S., Matsubara, T., Mikuriya, K., & Ishikawa, T. (2008) · Biochemical Journal · doi:10.1042/bj20071229 · Cited by 77
Porphyrin Homeostasis Maintained by ABCG2 Regulates Self-Renewal of Embryonic Stem Cells
Susanto, J., Lin, Y., Chen, Y.-N., Shen, C., Yan, Y., Tsai, S., Chen, C., & Shen, C.-N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004023 · Cited by 74
Ejendal, K. F. K., Diop, N. K., Schweiger, L. C., & Hrycyna, C. A. (2006) · Protein Science · doi:10.1110/ps.051998406 · Cited by 69
Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells
Miki, J., & Rhim, J. S. (2007) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4501018 · Cited by 69
Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells
Haizhi, L., Yi, T., & Wu, Z. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-135 · Cited by 71
Critical Appraisal of Ex Vivo Expansion of Human Limbal Epithelial Stem Cells
Tseng, S. C. G., Chen, S., Shen, Y., Chen, W., & Hu, F. (2010) · Current Molecular Medicine · doi:10.2174/156652410793937796 · Cited by 69
The role of cancer stem cells and the side population in epithelial ovarian cancer.
Fong, M., & Kakar, S. S. (2010) · PubMed · doi:10.14670/hh-25.113 · Cited by 68
Modulation of Oral Drug Bioavailability: From Preclinical Mechanism to Therapeutic Application
Kuppens, I. E. L. M., Breedveld, P., Beijnen, J. H., & Schellens, J. H. M. (2005) · Cancer Investigation · doi:10.1081/cnv-58823 · Cited by 79
Borght, S. V., Libbrecht, L. J., Katoonizadeh, A., van Pelt, J. F., Cassiman, D. M., Nevens, F., Lommel, A. V., Petersen, B. E., Fevery, J., Jansen, P. L. M., et al. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6912.2006 · Cited by 78
Metabolic Regulation of Hematopoietic Stem Cells
Morganti, C., Cabezas‐Wallscheid, N., & Ito, K. (2022) · HemaSphere · doi:10.1097/hs9.0000000000000740 · Cited by 86
Intricate relationship between cancer stemness, metastasis, and drug resistance
Dakal, T. C., Bhushan, R., Xu, C., Gadi, B. R., Cameotra, S. S., Yadav, V., Maciaczyk, J., Schmidt‐Wolf, I. G. H., Kumar, A., & Sharma, A. (2024) · MedComm · doi:10.1002/mco2.710 · Cited by 90
“…study was undertaken in 2001 and the outcomes showed that ABCG2 was an indicator of the SP phenotype and could be a potential biomarker for CSCs. 219 Many factors such as amino acids (glutamine), epigenetic enzymes (DNA methyltransferase) activity, and oxidative status (HIFs) can regulate the…”
BackgroundSuppression of ABCG2 inhibits cancer cell proliferation
Chen, Z., Liu, F., Ren, Q., Zhao, Q., Ren, H., Lu, S., Zhang, L., & Han, Z. (2009) · International Journal of Cancer · doi:10.1002/ijc.24796 · Cited by 75
Podoplanin and ABCG2: Malignant Transformation Risk Markers for Oral Lichen Planus
Peng, S., Liu, W., Zhou, Z., Qingbo, H., & Jiang, W. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0699 · Cited by 68
Teng, Y., Sheu, M., Hsieh, Y., Wang, R., Chiang, Y., & Hung, C. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.01.008 · Cited by 70
Lonetti, A., Antunes, I. L., Chiarini, F., Orsini, E., Buontempo, F., Ricci, F., Tazzari, P. L., Pagliaro, P., Melchionda, F., Pession, A., et al. (2013) · Leukemia · doi:10.1038/leu.2013.369 · Cited by 73
Zhao, Y., Alakhova, D. Y., Zhao, X., Band, V., Batrakova, E. V., & Kabanov, A. V. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102124 · Cited by 72
“Notably, expression of BCRP/ ABCG2 is a well-established feature of various stem/stem-like cells [46], and has been exploited to isolate the side population and non-side population cells using the Hoechst 33342 exclusion assay [47].”
MethodZhan, L., Zhang, H., Zhang, Q., Woods, C. G., Chen, Y., Xue, P., Dong, J., Tokar, E. J., Xu, Y., Hou, Y., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.041 · Cited by 74
Ovarian Cancer Stem Cells: A New Target for Cancer Therapy
Zhan, Q., Wang, C., & Ngai, S. M. (2013) · BioMed Research International · doi:10.1155/2013/916819 · Cited by 68
“Thus, Hoechst can be used to isolate stem-like cells in a variety of tissues, including bonemarrow, skeletal muscle, mammary epithelium [49, 50], and ovarian carcinomas [51].”
BackgroundKim, S., Kim, B.-K., Shim, J.-H., Gil, J.-E., Yoon, Y. D., & Kim, J. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl114 · Cited by 68
Searching for Prostate Cancer Stem Cells: Markers and Methods
Sharpe, B. P., Beresford, M. J., Bowen, R. L., Mitchard, J. R., & Chalmers, A. D. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9453-4 · Cited by 69
Xu, W.-R., Lin, H., Zhang, Y., Chen, X., Hua, B., Hou, W., Qi, X., Pei, Y., Zhu, X., Zhao, Z., et al. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-103 · Cited by 74
“Accumulating evidence has indicted that cancer stem cells (CSCs) are the roots of oncogenesis, cancer relapse and metastasis as they are resistant to all conventional therapies, even the advanced targeted therapy [1-6].”
BackgroundAdult Pancreas Generates Multipotent Stem Cells and Pancreatic and Nonpancreatic Progeny
Choi, Y., Ta, M., Atouf, F., & Lumelsky, N. L. (2004) · Stem Cells · doi:10.1634/stemcells.22-6-1070 · Cited by 68
Jia, Y., Chen, J., Zhu, H., Jia, Z., & Cui, M. (2015) · Oncology Reports · doi:10.3892/or.2015.4214 · Cited by 68
Crawford, R. R., Potukuchi, P. K., Schuetz, E. G., & Schuetz, J. D. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.080663 · Cited by 73
“During hematopoiesis, ABCG2 is highly expressed in primitive bone marrow stem cells and is reduced dramatically following differentiation (Zhou et al., 2001; Bunting, 2002; Scharenberg et al., 2002), providing further support that ABCG2 both protects and helps to maintain hematopoietic stem cells.”
InfluentialSelf-citationVargas, J. R., Stanzl, E. G., Teng, N. N. H., & Wender, P. A. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500161z · Cited by 72
Yi, L., Huang, P. C., Zou, X., Guo, L., Gu, Y., Wen, C., & Wu, G. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105144 · Cited by 65
Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
Niu, J., Peng, D., & Liu, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.896426 · Cited by 87
“Mice models engineered to knock-out ABCB1 or ABCG2 genes are particularly sensitive to drugs such as mitoxantrone and vinblastine, so the expression of these genes may represent a protective mechanism for HSCs (98).”
BackgroundIdentification of Notch-1 expression in the limbal basal epithelium.
Thomas, P. B., Liu, Y. H., Zhuang, F., Selvam, S., Song, S. W., Smith, R. E., Trousdale, M. D., & Yiu, S. C. (2007) · PubMed Central · Cited by 75
van der Heijden, J. W., Oerlemans, R., Tak, P. P., Assaraf, Y. G., Kraan, M. C., Scheffer, G. L., van der Laken, C. J., Lems, W. F., Scheper, R. J., Dijkmans, B. A. C., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24354 · Cited by 66
Chen, Y., Li, W. S., Hayashida, Y., He, H., Chen, S.-Y., Tseng, D. Y., Kheirkhah, A., & Tseng, S. C. G. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0677 · Cited by 66
Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells
Han, Shin, D. H., Kim, J. S., Weon, K. Y., Jang, C.-Y., & Kim, J.-S. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s95850 · Cited by 65
“5 13 The increased expression of these proteins may enhance the resistance of BCSCs to current anticancer therapies.”
Metadata
- Authors
- Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., & Sorrentino, B. P.
- Affiliations
- St. Jude Children's Research Hospital (US)
- University of Tsukuba (JP)
- Corresponding author
- Sorrentino, Brian P.
- ORCID
- Venue
- Nature Medicine
- Published
- 2001-09
- Volume
- 7
- Issue
- 9
- Pages
- 1028-1034
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1483167997
- Cited by
- 2,280
- References
- 37
- Citations by year
- 2026: 9 · 2025: 25 · 2024: 28 · 2023: 53 · 2022: 43 · 2021: 44 · 2020: 63 · 2019: 58 · 2018: 72 · 2017: 90 · 2016: 82 · 2015: 100 · 2014: 117 · 2013: 146 · 2012: 142
- FWCI
- 34.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL053749, P01HL53749, R01HL067366, R01-HL67366-01)
- National Cancer Institute (P 30CA 21765, P30CA021765)
- National Institute of General Medical Sciences (GM60904)
- National Institute of Environmental Health Sciences (ES05851)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- ABCG2, BCRP1, ABC transporters, side population cells, stem cells, hematopoietic stem cells, bone marrow, skeletal muscle stem cells, stem cell markers, stem cell differentiation, stem cell transplantation, drug efflux
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily G, Member 2, Animals, Bone Marrow Cells, Cells, Cultured, Female, Humans, Male, Membrane Glycoproteins, Mice, Inbred Strains, Mice, Mutant Strains, Neoplasm Proteins, Ribosomal Proteins, Stem Cells, Biomarkers, Antigens, CD, Cytokines, ATP-Binding Cassette Transporters, Antigens, CD34, Macrophage Inflammatory Proteins, Transplants, Chemokines, CC, ATP Binding Cassette Transporter, Subfamily B, Member 1, ATP-Binding Cassette, Sub-Family C Proteins, Mice, Tetraspanin 29
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.